Biotechnology Innovation Organization statement for the record to the U.S. House Committee on Small Business Subcommittee on Economic Growth, Tax, and Capital Access hearing on "American Ingenuity: Promoting Innovation Through the Tax Code,"
June 6, 2023
The global IP framework has enabled lifesaving innovation and provides a reliable legal foundation for companies to voluntarily license their IP to enhance research collaborations and provide timely, equitable global access to safe and effective therapeutics.
Letters, Testimony & Comments | May 26, 2023 | FDA Review, FDA Guidance, FDA Regulations
We recap a busy week, with activity on drug price controls and a look at alarming surges in measles around the world. (484 words, 2 minutes, 25 seconds)
Letters, Testimony & Comments | December 18, 2023 | FDA Review, FDA Guidance, FDA Regulations
BIO and the American Seed Trade Association submitted comments on USDA-APHIS' proposed exemptions of five types of genetic modifications a plant can contain and be exempt from regulations for the movement of organisms modified or produced through genetic engineering because the modifications could…
Letters, Testimony & Comments | January 30, 2024 | Policy & Regulatory, International Issues